James K. Schwarz

2.0k citations
27 papers · 1.4k indexed · 1 hit paper · h-index 12
Topics
Cancer Immunotherapy and Biomarkers (6 papers)Pancreatic and Hepatic Oncology Research (5 papers)Cancer Treatment and Pharmacology (4 papers)

In The Last Decade

James K. Schwarz

26 papers receiving 1.4k citations

Hit Papers

Expression of transcription factor E2F1 induces quiescent...19932026200420151993250500750

Peers

James K. Schwarz
Comparison fields: 5 of 89
  • Oncology 928
  • Molecular Biology 866
  • Genetics 213
  • Cell Biology 168
  • Cancer Research 154
Replace Timothy K. MacLachlan with:
Timothy K. MacLachlan United States
Matthew J. Cecchini Canada
Stuart Naylor United Kingdom
Meg R. Gerstenblith United States
Irina Golovleva Sweden
Donatella Malanga Italy
Raquel Villuendas Spain
Porcia T. Bradford United States
Shu Fen Wen United States
Hiroyasu Nagahama Japan
James K. Schwarz relative to Timothy K. MacLachlan United States Timothy K. MacLachlan's profile →
Citations per field
00.5×1.7×
Timothy K. MacLachlan · 1×
Citations per year

Countries citing papers authored by James K. Schwarz

Since Specialization
Citations

This map shows the geographic impact of James K. Schwarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James K. Schwarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James K. Schwarz more than expected).

Fields of papers citing papers by James K. Schwarz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James K. Schwarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James K. Schwarz. The network helps show where James K. Schwarz may publish in the future.

Co-authorship network of co-authors of James K. Schwarz

This figure shows the co-authorship network connecting the top 25 collaborators of James K. Schwarz. A scholar is included among the top collaborators of James K. Schwarz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James K. Schwarz. James K. Schwarz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 33
2 1
3 18
4 24
5 3
6 17
7 11
8 2
9 3
10 0
11 4
12
[Therapy of acute promyelocytic leukemia in Czechia: results and analysis of prognostic factors].
1
13 73
14 12
15 11
16 4
17
[Expression of cyclin-dependent kinase inhibitors in leukemia].
2
18 101
19
Expression of transcription factor E2F1 induces quiescent cells to enter S phasebreakdown →
845
20 207

About James K. Schwarz

James K. Schwarz is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Oncology (928 citations), Molecular Biology (866 citations) and Ophthalmology (97 citations). James K. Schwarz has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Joseph R. Nevins, D. Gale Johnson, W. Douglas Cress, Stephen H. Devoto, Srikumar Chellappan, Eric Smith, Laszlo Jakoi, Peter Brooks, Lyn March and Jeffrey Simpson. Their work appears in journals such as Nature, Journal of Clinical Oncology and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026